<DOC>
	<DOCNO>NCT01427309</DOCNO>
	<brief_summary>The aim study determine efficacy Fluzone High-Dose compare standard dose Fluzone laboratory-confirmed culture-confirmed influenza cause influenza types/subtypes similar ( laboratory-confirmed ) antigenically similar ( culture-confirmed ) contain respective annual vaccine formulation . Primary Objective : - To compare clinical efficacy Fluzone High-Dose Fluzone elderly adult , respect laboratory-confirmed influenza cause influenza viral types/subtypes , associate occurrence protocol-defined influenza-like-illnesses ( ILI ) . Secondary Objectives : - To compare clinical efficacy Fluzone High-Dose Fluzone elderly adult , respect laboratory-confirmed influenza , cause influenza viral types/subtypes , associate occurrence protocol-defined ILI . - To compare clinical efficacy Fluzone High-Dose Fluzone elderly adult , respect culture-confirmed influenza , cause influenza viral types/subtypes , associate occurrence protocol-defined ILI . - To compare clinical efficacy Fluzone High-Dose Fluzone elderly adult , respect culture-confirmed influenza cause viral types/subtypes antigenically similar contain respective annual vaccine formulation , associate occurrence modify Centers Disease Control Prevention ( CDC ) -defined ILI . - To compare clinical efficacy Fluzone High-Dose Fluzone elderly adult , respect culture-confirmed influenza cause influenza viral types/subtypes , associate occurrence modify CDC-defined ILI . - To compare clinical efficacy Fluzone High-Dose Fluzone elderly adult , respect culture-confirmed influenza cause viral types/subtypes antigenically similar contain respective annual vaccine formulation , associate occurrence respiratory illness . - To compare clinical efficacy Fluzone High-Dose Fluzone elderly adult , respect culture-confirmed influenza cause influenza viral types/subtypes , associate occurrence respiratory illness .</brief_summary>
	<brief_title>A Study Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults</brief_title>
	<detailed_description>The trial span 2 influenza season . Each study year , participant randomize receive one dose either Fluzone® High-Dose Fluzone® vaccine prior start influenza season follow end season . The duration participant 's participation respective study year 6 8 month , depend time enrollment .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged ≥ 65 year day vaccination Informed consent form sign date Able attend schedule visit comply trial procedure . Participation time study enrollment ( 4 week precede trial vaccination ) , plan participation year trial period , another clinical trial investigate vaccine , drug , medical device , medical procedure ( Note : Concomitant participation observational trial acceptable ) Vaccination influenza 6 month precede trial vaccination Systemic hypersensitivity egg , chicken protein , vaccine component , history lifethreatening reaction Fluzone HighDose Fluzone vaccine vaccine containing substance Personal history GuillainBarré Syndrome Dementia cognitive condition stage could interfere follow trial procedure Thrombocytopenia contraindicate intramuscular ( IM ) vaccination , judge investigator Bleeding disorder receipt anticoagulants 3 week precede inclusion , contraindicate intramuscular vaccination , judge investigator Current alcohol abuse drug addiction Subject deprive freedom administrative court order , emergency setting , hospitalize involuntarily Identified Investigator employee Investigator study center direct involvement propose study , identify immediate family member ( i.e. , parent , spouse , natural adopt child ) Investigator employee direct involvement propose study Moderate severe acute illness without fever ( oral temperature &gt; 99.0ºF [ &gt; 37.2ºC ] ) . If contraindication exists , vaccination defer individual medically stable and/or afebrile ( temperature ≤ 99.0 ºF [ ≤ 37.2ºC ] ) least 24 hour Signs symptom acute infectious respiratory illness . If exists , vaccination defer symptom resolve .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Trivalent Inactivated Influenza Vaccine</keyword>
	<keyword>High-Dose Trivalent Inactivated Influenza Vaccine</keyword>
	<keyword>Fluzone® High-Dose</keyword>
	<keyword>Influenza vaccine</keyword>
</DOC>